ANDAINJECTIONINJECTABLE
Approved
Aug 2004
Lifecycle
Post-LOE
Competitive Pressure
30/100
Mechanism of Action
base, hypoxanthine. Allopurinol and its oxypurinol metabolite inhibitor xanthine oxidase, the enzyme responsible for the conversion of hypoxanthine to xanthine and of xanthine to uric acid, the end product of purine metabolism in humans. Allopurinol does not disrupt the biosynthesis of purines. The…